Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-02-25 @ 11:47 PM
Study NCT ID:
NCT02952508
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-26
First Post:
2016-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia
Sponsor:
Cellectar Biosciences, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Waldenstrom Macroglobulinemia | View |
| None | Multiple Myeloma | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Small Lymphocytic Lymphoma | View |
| None | Lymphoplasmacytic Lymphoma | View |
| None | Marginal Zone Lymphoma | View |
| None | Mantle Cell Lymphoma | View |
| None | Diffuse Large B Cell Lymphoma | View |
| None | Central Nervous System Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Waldenstrom Macroglobulinemia | View |
| None | Non-Hodgkin Lymphoma | View |
| None | NHL | View |
| None | Relapsed | View |
| None | Refractory | View |
| None | Novel class | View |
| None | Pivotal | View |
| None | Phase 3 | View |
| None | Hematologic disease | View |
| None | Neoplasm | View |
| None | Plasma cell neoplasms | View |
| None | Paraproteinemias | View |
| None | Lymphoma | View |
| None | Immunoproliferative disorder | View |
| None | Blood protein disorders | View |
| None | Lymphoproliferative disorders | View |
| None | Antineoplastic agents | View |